Cancer became recently the leading cause of death in industrialized countries. Even though
standard treatments achieve significant effects in growth inhibition and tumor elimination …

Bombesin-related peptides and their receptors: recent advanc... : Current Opinion in
Endocrinology, Diabetes and Obesity Bombesin-related peptides and their receptors: recent …

Over the past 20 years, abundant evidence has been collected to suggest that gastrin-
releasing peptide (GRP) and its receptors play an important role in the development of a …

Gastrin-releasing peptide receptors (GRP-R) are upregulated in many cancers, including
prostate, breast, and lung. We describe a new radiolabeled bombesin (BBN) analog for …

Introduction: Despite remarkable advances in tumor treatment, many patients still die from
common tumors (breast, prostate, lung, CNS, colon, and pancreas), and thus, new …

The gastrin-releasing peptide receptor (GRPR) is found to be overexpressed in a variety of
human tumors. The aim of this study was to develop 18F-labeled bombesin analogs for PET …

The three mammalian bombesin (Bn) receptors (gastrin-releasing peptide [GRP] receptor,
neuromedin B [NMB] receptor, BRS-3) are one of the classes of G protein-coupled receptors …

The gastrin-releasing peptide receptor (GRPr) is overexpressed on various human tumors.
The goal of our study was the synthesis of new 18F-labeled bombesin analogues for the …

This following article is written for Prof. Abba Kastin's Festschrift, to add to the tribute to his
important role in the advancement of the role of peptides in physiological, as well as …

Radiolabelled receptor-binding peptides targeting receptors (over) expressed on tumour
cells are widely under investigation for tumour diagnosis and therapy. The concept of using …